髓系细胞视黄醇X受体信号促进老年小鼠白质修复与卒中恢复
本研究在18-22月龄C57BL/6J小鼠中采用远端大脑中动脉闭塞模型,探讨贝沙罗汀激活RXR对卒中后恢复的作用及髓系细胞特异性RXR信号机制。结果显示贝沙罗汀(5-10 mg/kg)改善感觉运动与认知功能,促进白质完整性修复,且这些获益在髓系RXR条件性敲除小鼠中被阻断。
要点
- 贝沙罗汀改善老年小鼠卒中后感觉运动与认知功能。
- 贝沙罗汀促进慢性期白质修复但不减少灰质萎缩。
- 髓系RXR信号介导贝沙罗汀的抗炎与促修复效应。
核心结论
- 髓系RXR信号促进老年雌雄小鼠长期卒中恢复,并激活抗炎与促修复机制。
- 贝沙罗汀作为潜在神经修复疗法值得进一步评估。
研究设计与样本
- 在18-22月龄C57BL/6J雄性和雌性小鼠中采用远端大脑中动脉闭塞诱导永久性局灶脑缺血。
- 通过卒中后给予贝沙罗汀实现药理激活,通过构建髓系细胞特异性RXR条件性敲除小鼠实现基因消融。
- 评估功能(感觉运动与认知)和结构恢复指标至卒中后35天。
主要发现
- 贝沙罗汀(5-10 mg/kg)改善转棒、足错和粘附去除测试的感觉运动表现,并减轻Morris水迷宫和被动回避测试的认知缺陷。
- 贝沙罗汀在远端大脑中动脉闭塞后35天改善白质完整性,但不影响3天时白质,也不阻止慢性损伤期灰质萎缩。
- 贝沙罗汀抑制免疫细胞浸润和促炎细胞因子产生,增强炎症消退性胞葬作用,促进长期少突胶质细胞生成和血管生成,营造促修复中枢神经系统微环境。
- 与年龄匹配野生型小鼠相比,老年RXR条件性敲除小鼠卒中结局显著恶化,且贝沙罗汀的功能和白质获益在RXR条件性敲除小鼠中被阻断。
临床怎么用
- 贝沙罗汀可能作为老年卒中患者神经修复治疗的候选药物,但需进一步临床评估。
- 髓系RXR信号是潜在治疗靶点,其激活可能促进白质修复和功能恢复。
局限性
- 研究仅在小鼠中进行,结果尚未在人类验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: As stroke is the leading cause of long-term disability in the elderly, effective pharmacological therapies for neurorestoration remain an unmet clinical need. RXR (retinoid X receptor) signaling regulates inflammation and tissue repair, but the downstream repair processes linking RXR activation to stroke recovery in the aged central nervous system remain incompletely defined. We used aged mice to test the hypotheses that (1) pharmacological RXR stimulation with the brain-penetrant pan-RXR agonist bexarotene boosts poststroke recovery and (2) myeloid cell-specific RXR signaling facilitates white matter repair and underlies the therapeutic effects of bexarotene. METHODS: Permanent focal cerebral ischemia was induced in 18- to 22-month-old C57BL/6J male and female mice by distal middle cerebral artery occlusion. Pharmacological RXR activation and genetic ablation were achieved by poststroke bexarotene administration and generation of myeloid cell-specific RXR conditional knockout mice, respectively. Functional (sensorimotor and cognitive performance) and structural measures of central nervous system recovery were assessed up to 35 days after stroke. RESULTS: Poststroke treatment with bexarotene (5-10 mg/kg) improved sensorimotor performance in the rotarod, foot fault, and adhesive removal tests and alleviated cognitive deficits in the Morris water maze and passive avoidance tests. Bexarotene improved white matter integrity at 35 days after distal middle cerebral artery occlusion, without impacting white matter at 3 days or preventing gray matter atrophy at chronic injury stages. Bexarotene also suppressed immune cell infiltration and proinflammatory cytokine production, enhanced inflammation-resolving efferocytosis, promoted long-term oligodendrogenesis and angiogenesis, and fostered a prorepair central nervous system microenvironment. Accordingly, stroke outcomes were markedly worsened in aged RXR conditional knockout mice compared with age-matched wild-type mice, and the functional and white matter benefits of bexarotene were blocked in RXR conditional knockout mice. CONCLUSIONS: Myeloid RXR signaling promotes long-term stroke recovery in aged mice of both sexes and engages anti-inflammatory and prorepair mechanisms. Bexarotene warrants further evaluation as a potential neurorestorative therapy for stroke.
引用
- Lyu J, Hassan S, Zhang W, et al. Myeloid Cell-Specific Retinoid X Receptor Signaling Facilitates White Matter Repair and Stroke Recovery in Aged Mice. Stroke. 2026. PMID: 42529831. doi:10.1161/STROKEAHA.126.055940
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。